BUPROPION HYDROCHLORIDE
- Product NDC
- 70934-489
- 11-digit product format
- 709340489
- Labeler code
- 70934
- Product ID
- 70934-489_a838e9f9-2bb4-b33d-e053-2a95a90ab1c0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPROPION HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA210497
- Marketing category
- ANDA
- Marketing start
- 2020-01-13
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-489-30 | 70934048930 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-489-30) | 2020-01-13 | 0000-00-00 | No | No | Current |
| 70934-489-90 | 70934048990 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-489-90) | 2020-06-15 | 0000-00-00 | No | No | Current |
| 70934-489-96 | 70934048996 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-489-96) | 2020-01-13 | 0000-00-00 | No | No | Current |